Emerald Health Therapeutics (CVE:EMH) Shares Down 3.8% – Should You Sell?

Shares of Emerald Health Therapeutics, Inc. (CVE:EMH) fell 3.8% during mid-day trading on Wednesday . The company traded as low as C$0.25 and last traded at C$0.26. 384,329 shares traded hands during trading, a decline of 40% from the average session volume of 644,760 shares. The stock had previously closed at C$0.27.

Emerald Health Therapeutics Price Performance

The company has a current ratio of 2.97, a quick ratio of 2.61 and a debt-to-equity ratio of 35.45. The stock has a market capitalization of C$52.28 million and a P/E ratio of -0.37. The stock has a 50 day moving average of C$0.26 and a 200-day moving average of C$0.26.

Emerald Health Therapeutics Company Profile

Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015. Emerald Health Therapeutics, Inc is headquartered in Vancouver, Canada.